Australia's most trusted
source of pharma news
Posted 30 July 2024 AM
Over the past five-and-a-half years, Australia has further edged itself into the therapeutic radiopharmaceutical clinical trials landscape, only losing out to the US as the preferred site for the industry.
A white paper produced by contract research organisation Novotech titled Radiopharmaceuticals Global Clinical Trial Landscape (2024) shows that from 2019 to 2024 YTD, the radiopharmaceutical sector has experienced significant growth in clinical trials globally, with 150 ongoing trials.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.